Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 81,671 | 45,413 | 175,315 | 127,145 | 61,575 |
| Depreciation Amortization | 11,419 | 5,875 | 17,592 | 13,202 | 8,907 |
| Income taxes - deferred | 3,195 | 23,117 | 42,066 | 15,169 | 19,176 |
| Accounts receivable | -41,717 | -20,184 | -78,778 | -52,332 | -35,768 |
| Other Working Capital | 41,938 | -27,436 | -17,183 | -18,539 | -3,111 |
| Other Operating Activity | 67,826 | 36,020 | 131,072 | 94,652 | 52,266 |
| Operating Cash Flow | $164,332 | $62,805 | $270,084 | $179,297 | $103,045 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 94,458 | 87,100 | 74,100 |
| PPE Investments | -8,018 | -3,766 | -21,982 | -15,241 | -9,836 |
| Net Acquisitions | -605,735 | -605,429 | -105,886 | -105,886 | -105,886 |
| Other Investing Activity | -3 | -2 | -307 | -351 | -348 |
| Investing Cash Flow | $-613,756 | $-609,197 | $-33,717 | $-34,378 | $-41,970 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 115,000 | 115,000 | 60,000 | 60,000 | 60,000 |
| Debt Issued | 240,000 | 240,000 | N/A | 0 | 0 |
| Debt Repayment | -12,000 | N/A | N/A | -640 | -290 |
| Common Stock Issued | 492,490 | 15,822 | 35,765 | 24,531 | 16,546 |
| Other Financing Activity | -119,920 | -6,200 | -56,715 | -57,694 | -58,468 |
| Financing Cash Flow | $715,570 | $364,622 | $39,050 | $26,197 | $17,788 |
| Exchange Rate Effect | -801 | 293 | -1,697 | -107 | 1,860 |
| Beginning Cash Position | 540,865 | 540,865 | 267,145 | 267,145 | 267,145 |
| End Cash Position | 806,210 | 359,388 | 540,865 | 438,154 | 347,868 |
| Net Cash Flow | $265,345 | $-181,477 | $273,720 | $171,009 | $80,723 |
| Free Cash Flow | |||||
| Operating Cash Flow | 164,332 | 62,805 | 270,084 | 179,297 | 103,045 |
| Capital Expenditure | -8,018 | -3,766 | -21,982 | -15,241 | -9,836 |
| Free Cash Flow | 156,314 | 59,039 | 248,102 | 164,056 | 93,209 |